Video: Preventing the next global health emergency

Serious bacterial infections are a major cause of death in hospitals and healthcare settings. Drug resistance makes these infections more difficult to treat. In turn, surgical procedures and chemotherapy carry greater risk. Global action to develop new treatments for drug-resistant infections can prevent the next global health emergency.

Video: On the trail of a new gonorrhoea treatment

GARDP is working on a novel antibiotic called zoliflodacin, the only drug being developed specifically to treat gonorrhoea. The treatment is currently being evaluated in a global phase 3 trial. One of the sites where the drug is being trialled is in the US city of Birmingham, Alabama.

Video: Uniting against antibiotic resistance

The development of antibiotics transformed our world, saving millions of lives and radically improving our health. Now, time with these drugs is running out. GARDP is calling on the world to raise €500 million to support the delivery of five new treatments by 2025 to tackle the drug-resistant infections that pose the greatest threat to global health and economic security.

Photo gallery: Investigating a gonorrhoea treatment in Birmingham, Alabama

Globally the infection rate of gonorrhoea is increasing, with 87 million new cases each year. Gonorrhoea has progressively developed resistance to globally recommended treatments and has been identified by the WHO as among a family of drug-resistant priority pathogens posing the greatest threat to health. The Global Antibiotic Research and Development Partnership (GARDP) is working […]

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.